We present in vitro and in vivo studies of yttrium-90 ( 90 Y)-labelled human serum albumin magnetic microspheres (HSAMMS) as multifunctional agent for bimodal radionuclidehyperthermia cancer therapy. The HSAMMS were produced using a modified emulsificationheat stabilization technique and contained 10-nm magnetite nanoparticles coated with citric acid, distributed as inhomogeneous clusters within the albumin microspheres. The average particle size of the complete HSAMMS was 20 µm, and they exhibited superparamagnetic behavior at 2 room temperature. 
cheap, and can be made in a variety of ways. However, their use in therapy is limited, mainly due to the nonspecific targeting. Also, due to their tendency to agglomerate or to be rapidly covered with plasma proteins in the blood, they are quickly cleared by macrophages before they can reach the target cells [8] . The specific targeting can be improved either by tuning the particle size, which determines the particles' preference for a specific organ [8] , or by using a large magnetic-field gradient that is capable of retaining the MNPs within the application volume around and inside the target location [6, 7] .
Albumin microspheres have received a lot of attention in recent decades as efficient drug-delivery vehicles because they are easy to prepare in defined sizes and carry reactive groups (amino and carboxylic groups) on their surfaces that can be used for radionuclide, chelator, antibodies binding and/or other surface modifications. Loaded with a sufficient amount of magnetite nanoparticles these microspheres might be used in hyperthermia treatment at a localized disease site where they could be delivered, after intravenous injection, by either passive means (e.g., trapping by size) or active means (e.g., magnetic targeting). Since hyperthermia alone is ineffective in most cases of cancer it needs to be combined with other forms of cancer therapy, such as radiation therapy. Hyperthermia may make some cancer cells more sensitive to radiation or harm other cancer cells that radiation cannot damage. When hyperthermia and radiation therapy are combined, they are often given within an hour of each other [ 9] .
Albumin microspheres currently have many clinical applications as carriers of diagnostic and therapeutic radionuclides. Labelled with 99m Tc they are routinely used for lung-perfusion scintigraphy [10] , while by labelling with 188 Re they could be applied in internal radiation therapy [11, 12, 13, 14] . Furthermore, albumin microspheres have been used as carriers of 67 Ga [15] , 68 Ga [16] , 177 Lu, 86 Y and 90 Y [17] . In these cases, chelators were attached onto the surface 4 of the spheres and the particles were labelled by subsequent complexation of the radionuclides.
In this work yttrium-90 ( 90 Y) was selected for the labelling of HSAMMS as a clinically acceptable, long-range, β-emitting radionuclide with optimal nuclear-physical characteristics for use in radionuclide therapy. Yttrium-90 is a pure, high energy β-emitter (Emax β of 2.27 MeV)
with a half-life of 64.1 h [18] and it can produce biological damage over a distance that is determined by the range of the radionuclide emission (mean/maximum penetration depth is 3.6/11 mm in the soft tissue) [19] . There are currently two commercially available 90 Ymicrosphere products -glass microspheres [20] and resin microspheres [21] -that are clinically useful for the selective internal radiation treatment (SIRT) of primary and metastatic liver cancer [22] . Besides being used in radionuclide therapy, radionuclides provide opportunities for the investigation of the physicochemical properties and biodistribution patterns of newly developed nano-and micro-particles [23] .
This study reports on the synthesis of human serum albumin microspheres with encapsulated citric acid-coated magnetite nanoparticles and their effective labelling with 90 Y for possible use in bimodal radionuclide and hyperthermia cancer therapy. We discuss the results from the structural and magnetic characterization as well as their efficiency as heating agents through specific power-absorption measurements. 
Synthesis of magnetite and citric acid-coated magnetite nanoparticles
Citric acid-coated magnetite nanoparticles were prepared using a two-step approach (post-synthesis coating) [24] [25] [26] and a co-precipitation method initially developed by Massarat [27] . Aqueous solutions (20 ml each) of 0. 
Preparation of HSAMMS
HSAMMS were prepared using an emulsification technique, described previously [28] with slight modifications, and stabilized by heat denaturation. Cottonseed oil was used as the oil phase and a mixture of HSA (1ml 20% HSA) and the previously prepared ferrofluid (0.5 ml, 88 mg) as the water phase. The HSA-ferrofluid mixture was added slowly (during 10 min) dropwise with a syringe using a 21-gauge needle into the cottonseed oil at room temperature and vigorously stirred for 30 min. Afterwards the temperature was increased to 100 °C and the mixture was stirred for another 30 min. This resulted in the rapid evaporation of the existing water and the albumin's irreversible denaturation, causing the formation of solid microspheres.
The HSAMMS were filtered on Whatman No.5 filter paper, washed several times with ether to remove any adherent oil and vacuum dried in a desiccator overnight. The final HSAMMS were stored at 4 °C until use. The uniformity of the size of the microspheres was checked with light microscopy.
Experimental methods for characterization of the samples
An integrated study of the structure of the microspheres was made by combining High-resolution transmission electron microscopy (TEM) measurements were carried out using a Jeol JEM 2100 HR electron microscope operating at 200 kV. The samples were prepared by ultra-sonification in ethanol and deposited on a conventional carbon-covered copper HRTEM grid. After drying, the samples were examined by HRTEM.
Hysteresis loops were measured at 300 K in the zero-field-cooled (ZFC) regime using the Quantum Design SQUID-based magnetometer MPMS XL-5.
The microspheres were submitted to alternating magnetic fields (AMF) using a homemade applicator, consisting of a resonant LC tank working at close to the resonant frequency.
The specific power absorption (SPA) of the samples (f = 355 kHz, H = 47 kA/m) was measured inside a thermally insulated Dewar. Temperature data were taken using a fiber-optic temperature probe immune to the RF environment. Before each experiment, the temperature evolution was measured for 5-10 min, with the RF source turned off, in order to establish a T-baseline. 8
Labelling of HSAMMS with yttrium-90
For the radiolabelling of HSAMMS, to a suspension of 10 mg of HSAMMS in 1 ml at pH HSAMMS were re-suspended in 2ml of 0.9 % NaCl solution (saline) and used in the subsequent studies.
The labelling yield was determined as the ratio of the measured HSAMMS-associated activity obtained after magnetic separation and the known activity used for the labelling. The radiolabelled particles were magnetically precipitated, but because of the risk of withdrawing labelled HSAMMS, the supernatant was not removed completely, so the activity was measured separately in a 0.1 ml aliquot of the supernatant and the remaining sample (radiolabelled HSAMMS and 1.9 ml supernatant). The acquired radioactivity was calculated as follows: the activity of the remainder -the activity of the 0.1 ml supernatant x1. Since yttrium-90 is a pure β-emitter it can only be detected by "bremsstrahlung" [29, 30] measured in a cross-calibrated well counter Capintec CRC-15 beta counting calibrator (Ramsey, NJ USA) and well-type NaI(Tl) gamma counter (Wallac Compu Gamma Counter LKB, 9 Finland). The results are reported as the mean of at least three measurements ± standard deviation.
In vitro stability of 90 Y-labelled HSAMMS
In vitro stability studies were performed by incubating 2 mg of 90 Y-HSAMMS in 2 ml of either saline or human serum at 37 °C. At various times after the preparation the radiolabelled particles were magnetically precipitated and the activity was measured separately in a 0.1 ml aliquot of the supernatant and the remaining sample (radiolabelled HSAMMS and 1.9 ml supernatant). The HSAMMS bound radioactivity was calculated as follows: the activity of the remainder -the activity of the 0.1 ml supernatant x 1.9. The results of the HSAMMS-associated radioactivity were compared with a radiochromatography analysis performed on SG strips (ITLC-SG) with saline as the mobile phase at different times after the preparation for up to 94 h. sacrificed by cervical dislocation. The following organs were dissected out: muscle (hind leg), bone (the complete left femur), heart, lungs, liver, kidneys, spleen, stomach (emptied) and intestine (emptied) and a blood sample (1ml). Selected organs and tissues were disintegrated and solubilized in a final volume of 10 ml to reach an identical geometry and similar probe density for bremsstrahlung measurements of the 90 Y radioactivity. The uptake into the organs was expressed as a percentage of the injected total radioactivity (%ID/organ) and per ml of blood, except for the radioactivity in the muscle, which was estimated by assuming a muscle weight of 40% of the total body weight. The amount of injected activity was calculated from the activity of the injection syringes before and after the injection because a significant quantity of the labelled microspheres stay attached to the plastics of the syringe. The results are reported as mean values ± standard deviation.
Biodistribution and in vivo

Results and discussion
Magnetite and ferrofluid preparation
In the absence of any surface coating, magnetic nanoparticles have hydrophobic surfaces with a large surface-area to volume ratio. Due to the hydrophobic interactions between the particles, they agglomerate and form large clusters with very strong magnetic dipole-dipole attractions among them [31] . In order to obtain a stable colloidal dispersion with the desired magnetic characteristics, different coating materials such as starch [32] , polyethylene glycol/polyacril acid (PEG/PAA) [33] , polylactic acid (PLA) [34] , citric acid [35] , oleic acid [36] , decanoic acid and nonionic acid [37] have been applied. In the present study a citric acid coating was used to prevent the magnetite aggregation and to achieve good colloidal stability.
The obtained citric acid-coated magnetite nanoparticles kept their colloidal characteristics for up to 3 months, with a very low level of sedimentation. It was assumed that citric acid can be adsorbed onto the surface of the magnetite nanoparticles by coordinating ≡Fe-OH sites via one or two of the carboxylate functionalities, depending on the steric necessity and the curvature of the surface. The carboxylic acid group on the citric acid exposed to the solvent stabilized the fluids based on the electrostatic repulsion between the particles [38, 39, 40] . At a higher citric acid concentration a tighter packed surface structure can be supposed, e.g., instead of two, only one carboxylate group of citric acid will be bound to the ≡Fe-OH sites, forming the surface of magnetite particles [41] . Therefore, the presence of available carboxylic groups provides a route to an extended bond formation with albumin. Also, individual and separated magnetic nanoparticles allowed better encapsulation in the HSA microspheres than the aggregates.
The representative FTIR measurements for citric-acid-coated magnetite nanoparticles and pure citric acid are shown in Fig. 1 . The citric acid coating of the magnetite was confirmed by the presence of the peaks at 1560 and 1400 cm -1 . The 1695 cm -1 peak, assignable to the C=O vibration (asymmetric stretching) from the COOH group in neat citric acid, after the binding of the citric acid to the magnetite surface, was shifted to a lower wave number. The neighbor band at 1400 cm -1 was assigned to the symmetric stretching of C=O. The low-intensity peak at 540 cm -1 can be associated with the stretching and torsion vibration modes of the magnetite. The large and intense band at approximately 3200 cm -1 could be assigned to the structural OH groups as well as to the traces of molecular water and citric acid.
Preparation of the HSAMMS
The microspheres and particles designed for use as radionuclide carriers in radionuclide therapy must comply with the high standards relating to biocompatibility and biodegradability.
From the production side, they must be easy to radiolabel and provide a high radiochemical stability of the labelled products against leaching of the radionuclide in vivo [42] . The high density of the 90 Y-labelled glass microspheres used in the conventional therapy gave rise to problems during injection and, due to the non-biodegradability of the particles, they usually cause anatomical distress [43] . Resin microspheres are biocompatible but not biodegradable and suffer from a low specific activity, which requires the administration of large amounts of particles causing different adverse side-effects, like post-embolization syndrome [44] . To overcome these problems we synthesized biodegradable magnetic microspheres made from human serum albumin. Since the chemically cross-linked albumin microspheres showed nonuniform sizes and aggregates and due to the fact that heat-stabilized HSAMMS were found to be more stable [45] , in our preparation we used the thermal denaturation method. Higher temperatures and longer heating times generally produce harder, less porous and more slowly degradable spheres [46] . Patil also reported that the stabilization of albumin microspheres (without loaded magnetite) at low temperatures (100-105 °C) resulted in a less smooth spherical geometry and some irregularity in the shape than when stabilizing at a higher temperature (170-175 °C) [46] . The reason for the smooth and compact surface of the albumin microspheres without magnetite is attributed to the preparation procedure in which the inner albumin phase of the water-in-oil emulsion was immediately solidified at high temperature with constant stirring.
To investigate the effect of different temperatures on the geometry of the microspheres, the preparation of the HSAMMS was carried out at 100 °C and at higher temperatures (up to 170 °C). All the HSAMMS batches gave the same rough surface morphology. Increasing the temperature to 170 °C does not affect the surface morphology and a smooth surface was not formed, probably due to the presence of magnetite.
We found that several factors determined the final magnetite loading of the microspheres, such as the magnetite-to-albumin ratio, the stirring rate of the emulsion and the average size of the MS. For the synthesis of the HSAMMS we used the highest possible ratio of ferrofluid to albumin (obtained in our experiments) in order to have a better magnetic response. Besides the amount of magnetite material, its location and long retention inside the albumin microspheres are important factors when considering the characteristics of any magnetic microspheres. Even microspheres with adsorbed magnetic particles will respond to an external magnetic field, but they would not be considered as a stable as the adsorbed magnetic particles may detach from the surface after their introduction to a physiological medium.
Structure and thermal analysis of citric acid-coated magnetite and HSAMMS
The crystal structure of the pure Fe 3 O 4 as well as Fe 3 O 4 in both citric acid-coated magnetite and HSAMMS was checked using the X-ray diffraction technique (XRD). 
FESEM, SEM/FIB and HRTEM analysis of magnetite, citric acid-coated magnetite and HSAMMS
The morphology and internal composition of the HSAMMS were assessed by FESEM and dual-beam SEM/FIB microscopy. As can be seen from the secondary-electron images shown in Figures 4a and 4b the HSAMMS particles are spherically shaped with sizes spanning from 10 to 70 µm. The surface of the microspheres is rough and, according to an energy-dispersive X-ray analysis (EDX), no detectable amounts of Fe-containing material can be found on their surface.
The internal 3D distribution of the nanoparticles was analyzed by cross-sectioning a single microsphere using FIB, and further reconstruction of the slices into a 3D perspective (Figure 4 c,   d ). We found a cluster distribution of high-contrast areas corresponding to the magnetic nanoparticles inside the microsphere, as confirmed by an EDX analysis of these spots (see Fig.   5 ).
Close to circumference some of the smaller spheres were electron transparent to the electron beam. Fig. 6 shows bright-field TEM images of the magnetite nanoparticles embedded in the organic matrix. It is mainly spherical particles that are seen, with a small amount of embedded aggregates. The magnetic nanoparticles appeared to be uniform in size from TEM images, with an average size of about 8-10 nm.
Hysteresis loops
The hysteresis loops of the samples M(H), recorded at 300 K, are shown in 
Labelling of HSAMMS with yttrium-90
The radio-tracer technique, possessing high sensitivity, credibility and freedom from interference, is a relevant approach to study the biodistribution of novel particles [47] .
Nevertheless, there are still some limitations to the methods that can be used for radiolabelling [48] . Firstly, the binding of the radionuclide has to be irreversible in order to prevent their escape to other tissues or organs. This problem exists even in newly developed, DOTA (1,4,7,10- 
In vitro stability studies
The results of both methods (magnetic precipitation and ITLC-SG) showed that less than 4.1% of the 90 Y dissociated from the surface of the 90 Y-HSAMMS in saline, and a slightly increased percentage (6.9%) in the serum, after 1 h (Fig. 8) . Even without the surface modification the 90 Y remained bound to the HSAMMS for a time period sufficient for a further in vivo application. The non-particle bound radioactivity consists only of the free 90 Y, moving with the solvent front (R f =0.9-1.0), and no other degradation products were found. The scanning electron microscopy images (not shown) revealed that the microspheres have the same characteristic morphology for a 7-day incubation period in HSA at 37 °C. Therefore, the leaching of the 90 Y is only the result of its detaching from the HSAMMS surface, but not the degradation of the HSAMMS.
Biodistribution study
The biodistribution and in vivo stability of the labelled HSAMMS were studied, after the showed increased perfusion in the tumor region, leading to a higher oxygen concentration [53] .
Most human tumors increased the blood flow under hyperthermia and for hours later. Higher perfusions can increase the radionuclide delivery and oxygenation required to enhance the freeradical-dependent cell death in radiotherapy [54] .
The results of the biodistribution of the 90 Y-HSAMMS 1h after injection ( Finally, the heating efficiency of the HSAMMS obtained from the power-absorption measurements (f=357 kHz, H = 47 kA/m) showed a heating rate of 3.95 K/min, which could be enough to reach the temperature range required for thermally induced cell apoptosis by hyperthermia. The SPA value obtained from these measurements was 13.8 W/g. Although this is a moderate value when compared to previous reports [6, 7] , the heating rate could be further increased by increasing the actual concentration of the magnetic microsphere in the target area.
Conclusions
We have synthesized a magnetic, microstructured composite based on citric acid-coated 
